Publications Office of the EU
DELIVERY OF LENALIDOMIDE 2.5 MG, 5 MG, 7.5 MG,10 MG, 15 MG, 20 MG, 25 MG CAPSULES TO THE ZIEKENHUISAPOTHEEK - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

DELIVERY OF LENALIDOMIDE 2.5 MG, 5 MG, 7.5 MG,10 MG, 15 MG, 20 MG, 25 MG CAPSULES TO THE ZIEKENHUISAPOTHEEK Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    02/10/2025
  • Deadline
    03/11/2025
  • Opening of tenders
    03/11/2025
  • Today
    19/11/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
Yes
Buyer
UZ Leuven
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: BE242 Arr. Leuven
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
2,230,890.51 EUR
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
PPP0WC-566/5791/P8652
Description

Explanation: The subject of the contract is the supply of Lenalidomide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg capsules to the hospital pharmacy The medicinal product in question must in any case be registered/authorised for placing on the market in Belgium in accordance with the relevant legislation and also be reimbursable in accordance with the regulations of the INAMI. In view of the current patient database treated with Lenalidomide, the tenderer must demonstrate that there is a minimum of reimbursability in accordance with the regulations of the INAMI with regard to all the following paragraph numbers according to Chapter IV of the list of reimbursable proprietary medicinal products (as described in Royal Decree of 01.02.2018), and this for the entire duration of the agreement. Reimbursability within these paragraphs is a minimum requirement (cf. III: Minimum requirements). Paragraph Number Contents Combination 4590000 Multiple myeloma with at least 1 prior treatment Dexamethasone 7180000 Myelodysplastic syndrome with 5q deletion / 7940000 No previously treated multiple myeloma, no stem cell transplantation possible Melfalan and prednisolone 9010000 Maintenance treatment newly diagnosed multiple myeloma after autologous stem cell transplantation / 9440000 Relapsed or refractory mantle cell lymphoma (MCL) / 10130000 No previously treated multiple myeloma, no stem cell transplantation possible Dexamethasone and bortezomib, followed by only combination with dexamethasone 11650000 Follicular lymphoma (grade 1, 2, or 3a), relapsed or refractory after a previous treatment consisting of combination of chemotherapy with at least 2 cycles of an anti-CD20 therapy targeted Rituximab 12410000 Recidive diucous large cell lymphoma (BCL), relapsed or refractored cell lymphoma (CLCL) are expected to be in the same autophagnable stem cell transplantation during the same period. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://www.publicprocurement.be
Tenders may be submitted
Electronic submission: required
https://www.publicprocurement.be
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
03/11/2025 09:00
Place of performance
BE Belgique/België
BE242 Arr. Leuven
CPV code

33600000 - Pharmaceutical products

33652000 - Antineoplastic and immunomodulating agents

33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

33652100 - Antineoplastic agents

Award method
Criterion:
Type: cost
Description: Netto kost ziekenhuis
Weight (percentage, exact): 70
Criterion:
Type: quality
Description: Gebruiksgemak en veiligheid verpakking
Weight (percentage, exact): 20
Criterion:
Type: quality
Description: LEVERINGSGARANTIE EN LEVERINGSTERMIJN
Weight (percentage, exact): 10
Estimated value
2,230,890.51 EUR
Final contracted value
Not available
Award of contract
Not available
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.